Anthraquinone Derivative Reduces Tau Oligomer Progression by Inhibiting Cysteine‐Cysteine Interaction
Abstract Tau protein is a natively unfolded protein whose primary role is to participate in axonal transport closely associated with microtubules. Neurodegenerative disorders including Alzheimer's disease and Tauopathies involved tau protein that is found hyperphosphorylated in vivo; then, tau...
Main Authors: | Dr. Carlos Areche, Francisca Zapata, Mathias González, Esteban Díaz, Rubén Montecinos, Marcos Hernández, Dr. Francisco Melo, Dr. Alberto Cornejo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley-VCH
2019-05-01
|
Series: | ChemistryOpen |
Subjects: | |
Online Access: | https://doi.org/10.1002/open.201800222 |
Similar Items
-
Mical modulates Tau toxicity via cysteine oxidation in vivo
by: Engie Prifti, et al.
Published: (2022-04-01) -
Tau oligomers
by: Naruhiko eSahara, et al.
Published: (2014-01-01) -
Targeting Tau to Treat Clinical Features of Huntington's Disease
by: Maria Masnata, et al.
Published: (2020-11-01) -
Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target
by: Sebastian S. Oakley, et al.
Published: (2020-11-01) -
TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia
by: Mauro Montalbano, et al.
Published: (2020-12-01)